The following list of investigators have active research in some aspect of drug discovery.

Investigator Research Focus Department Email
Burns Blaxall, Ph.D. Pharmacologic treatments for heart failure Medicine Email Icon
Rashid Deane, Ph.D. Small molecule therapeutics for neurodegenerative diseases, including Alzheimer's disease Neurosurgery Email Icon
Paul Dunman, Ph. D. High throughput screening for novel anti bacterial agents Microbiology & Immunology Email Icon
Rudi Fasan, Ph. D. Chemo-enzymatic synthesis of natural product derivatives with anticancer and antimalarial activity Chemistry Email Icon
Jonathan Friedberg, M.D. Kinase inhibitors for treatment of Iymphoma Medicine Email Icon
Harris Gelbard, M. D. Development of drugs for age-related and inflammatory diseases that target ancient caloric restriction pathways Neurology Email Icon
David Goldfarb, Ph.D. High throughput identification and development of novel lifespan extending compounds Biology Email Icon
Craig Jordan, Ph.D. Novel small molecules to selectively target leukemia cells Medicine Email Icon
Karl Kieburtz, M.D. Human clinical studies of novel therapeutics for various diseases Neurology Email Icon
Baek Kim, Ph.D. Ribonucleotide-based inhibitors of HIV-1 RT; Akt
inhibitors for eradication of HIV-1 infection in macrophages"
Microbiology & Immunology Email Icon
Damian Krysan, Ph.D. Antifungal drug discovery Pediatrics Email Icon
Hartmut Land, Ph.D. Gene interactions in oncogenesis Biomedical Genetics Email Icon
Joe Miano, Ph.D. Small molecule inhibitors of genes that regulate pathologic blood vessel contraction Medicine Email Icon
Ben Miller, Ph.D. Chemical synthesis of small molecule ligands; novel RNA-directed therapies for HIV/AIDS Dermatology Email Icon
Alan Smrcka, Ph.D. High throughput identification of novel inhibitors of G beta gamma signaling Pharmacology & Physiology Email Icon
Harold Smith, Ph.D. Small molecule drugs targeting HIV-1 Vif and APOBEC3G Biochemistry & Biophysics Email Icon
Harry Stern, Ph.D. Small molecule docking and affinity calculations Chemistry Email Icon
Charles Thornton, M.D. Novel therapeutics targeting triplet repeat transcripts for treatment of myotonic muscular dystrophy Neurology Email Icon
Joseph Wedekind, Ph.D. Structural analysis of HIV-1 Vif and APOBEC3G Biochemistry & Biophysics Email Icon

Investigators Directory